- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic hyperkalaemia
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 670KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 427KB)
Sodium zirconium cyclosilicate – March 2024
Sodium Zirconium Cyclosilicate: Sachet containing powder for oral suspension (as hydrate) 5 g, Sachet containing powder for oral suspension (as hydrate) 10 g; Lokelma®
Last updated
30 May 2025
